Outcomes of the POG 9340/9341/9342 Trials for Children with High-Risk Neuroblastoma: A Report from the Children’s Oncology Group

BACKGROUND: From 1993 through 1995, the Pediatric Oncology Group (POG) enrolled patients with high-risk neuroblastoma on 3 sequential, conjoined studies: a phase II induction window (9340), followed by intensive multiagent induction chemotherapy (9341), and subsequent myeloablative therapy with auto...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Zage, Peter E., Kletzel, Morris, Murray, Kevin, Marcus, Robert, Castleberry, Robert, Zhang, Yang, London, Wendy B., Kretschmar, Cynthia
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4426094/
https://ncbi.nlm.nih.gov/pubmed/18704922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21713
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados